Effect of nateglinide on the incidence of diabetes and cardiovascular events.

Схожие документы

• Effect of valsartan on the incidence of diabetes and cardiovascular events.
  по: McMurray, J, и др.
  Опубликовано: (2010)
• Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
  по: Califf, R, и др.
  Опубликовано: (2008)
• Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
  по: Krum, H, и др.
  Опубликовано: (2010)
• Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
  по: Mcmurray, J, и др.
  Опубликовано: (2011)
• Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
  по: Currie, G, и др.
  Опубликовано: (2017)